XBiotech Inc (XBIT) — Cash Flow Reinvestment Rate

Latest as of December 2022: 1.45x

XBiotech Inc (XBIT) has a Cash Flow Reinvestment Rate of 1.45x as of December 2022, reinvesting $3.91 Million (capex $132.00K plus investments $-3.77 Million) from operating cash flow of $2.70 Million. Explore XBiotech Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.45x
(Capex + Investments) / Operating CF

Total Reinvested

$3.91 Million
Capex + Investments

Operating Cash Flow

$2.70 Million
USD

Capital Expenditures

$132.00K
USD

XBiotech Inc Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for XBiotech Inc across 1 annual periods. Also explore balance sheet size of XBiotech Inc for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for XBiotech Inc (2021–2021)

Year-by-year capital reinvestment analysis for XBiotech Inc. For live market cap and broader valuation context, see XBIT company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.10x $7.05 Million $69.44 Million $3.52 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow